JAK2 and Hepatic fibrosis: In another study, it was demonstrated that activation of Janus kinase-2 (JAK-2) induced hepatic fibrosis is mediated through stimulation of ATR1 and prevented by pharmacologic inhibition of JAK-2 [31].